分享 收藏

Recombinant Bovine GCP-2/CXCL6

品牌：翌圣生物
产地：
供应商报价：面议

翌圣生物科技(上海)股份有限公司更新时间：2024-12-24 09:03:45

销售范围售全国

入驻年限第1年

营业执照已审核

同类产品趋化因子(83件)

立即扫码咨询

联系方式：400-611-1883

联系我们时请说明在仪器网（www.yiqi.com）上看到的!

扫码分享

为您推荐

Recombinant Human Eotaxin-3/CCL266 重组人Eotaxin-3/CCL26

Recombinant Human Exodus-2/CCL21重组人 Exodus-2/CCL21
Recombinant Human I-309/CCL1重组人 I-309/CCL1

Recombinant Human LD78β/CCL3L1 重组人LD78β/CCL3L1
Recombinant Human MIP-1α/CCL3重组人MIP-1α/CCL3

Recombinant Human MCP-1/CCL2 重组人MCP-1/CCL2

详细介绍

GCP-2 also known as CXCL6, is a CXC chemokine initially isolated as a neutrophil chemoattractant from the MG-63 osteosarcoma cell line. Among human CXC chemokines, GCP-2 is most closely related to ENA-78 (78% amino acid (aa) sequence identity in the mature peptide region and 86% identity in the signal sequence). The structure and sequence of the genes for human GCP-2 and ENA-78 also exhibit close similarity suggesting the two genes may have originated from a gene duplication. LIX (LPS-induced CXC chemokine) was initially cloned as a gene induced by LPS in mouse fibroblasts. The predicted LIX protein sequence is identical to a previously purified mouse protein designated mouse GCP-2 based on its amino sequence similarity (60% sequence identity) to human GCP-2. Mouse GCP-2/LIX is also 54% identical with human ENA-78 at the amino acid sequence level.

Product Properties

Synonyms	Chemokine alpha 3, CXCL6, GCP-2, CXCL6, member b
Accession	P80221
GeneID	281735
Source	E.coli-derived bovine GCP-2/CXCL6 protein, Gly37-Asn112.
Molecular Weight	Approximately 8.0 kDa.
AA Sequence	GPVAAVVREL RCVCLTTTPG IHPKTVSDLQ VIAAGPQCSK VEVIATLKNG REVCLDPEAP LIKKIVQKIL DSGKNN
Tag	None
Physical Appearance	Sterile Filtered White lyophilized (freeze-dried) powder.
Purity	>97% by SDS-PAGE and HPLC analyses.
Biological Activity	The biological activity determined by a chemotaxis bioassay using human neutrophils is in a concentration range of 10-50 ng/ml. Fully biologically active when compared to standard.
Endotoxin	< 0.1 EU per 1μg of the protein by the LAL method.
Formulation	Lyophilized from a 0.2 μm filtered concentrated solution in 20 mM PB, 500 mM NaCl, pH 7.0.
Reconstitution	We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20℃. Further dilutions should be made in appropriate buffered solutions.